Colony Group’s REGENERX BIOPHARMACEUTICALS RGN Stock Holding History

Colony Group’s Portfolio RGN Stock Details RGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15,000	Closed	-$3K	–	747
2020 Q1	$3K	Buy	+15,000	New	+$3K	﹤0.01%	675
2019 Q3	–	Sell	-10,000	Closed	-$2K	–	741
2019 Q2	$2K	Hold	10,000	–	–	﹤0.01%	721
2019 Q1	$2K	Hold	10,000	–	–	﹤0.01%	632
2018 Q4	$2K	Hold	10,000	–	–	﹤0.01%	493
2018 Q3	$2K	Buy	+10,000	New	+$2K	﹤0.01%	503

Other funds holding RGN

WJWM

Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $400M AUM 21.87% 1-Year Est. Return

Colony Group's RGN Position: Q2 2020 in Review

Colony Group sold out of REGENERX BIOPHARMACEUTICALS (RGN) in Q2 2020, closing a stake of 15,000 shares — an estimated $3K sold.

Colony Group first reported a position in RGN in Q3 2018 and held it in 5 quarters. The position peaked at $3K in Q1 2020. 2 funds tracked by Wall St. Rank hold RGN as of Q2 2020.

Colony Group reported no remaining REGENERX BIOPHARMACEUTICALS position as of Q2 2020 after selling out during the quarter.
Colony Group sold 15,000 REGENERX BIOPHARMACEUTICALS shares in Q2 2020, an estimated $3K.
Colony Group first reported a position in REGENERX BIOPHARMACEUTICALS in Q3 2018 and held it in 5 quarters.
Colony Group's REGENERX BIOPHARMACEUTICALS position peaked at $3K in Q1 2020.
2 funds tracked by Wall St. Rank held REGENERX BIOPHARMACEUTICALS as of Q2 2020.

Based on Colony Group's 13F filing for Q2 2020, filed 13 Aug 2020.